NCT04267276View on ClinicalTrials.gov

A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body

PHASE1TerminatedINTERVENTIONAL
Enrollment

7

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

April 2, 2020

Study Completion Date

April 2, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Part 1: BI 1265162 - intravenous

Intravenous solution

DRUG

Part 2: BI 1265162 - oral

Oral solution

Trial Locations (1)

9728 NZ

PRA Health Sciences Onderzoekscentrum Martini, Groningen

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04267276 - A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body | Biotech Hunter | Biotech Hunter